Journal
PHARMACEUTICS
Volume 13, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics13111892
Keywords
bacterial ghosts; gene E; vaccines; immune; delivery system
Categories
Funding
- Natural Science Foundation of China [51901160, 31971301]
- Natural Science Foundation of Zhejiang Province [LQ19E010004, LQ20C200015, LQ20C020003]
- Fundamental Research Funds for Central Universities [2020CDJQY-A061, 2018CDHB1B08]
- Wenzhou Scientific research project [S2020005, Y2020201]
Ask authors/readers for more resources
Bacterial ghosts (BGs) are utilized as vaccine delivery systems and adjuvants, with increasing interest in developing novel BG-based delivery systems for biomedical applications. BGs, with intact bacterial cell membranes, possess inherent immunogenicity for targeted drug delivery and controlled release, offering protection to drugs from external interference.
Bacterial ghosts (BGs) are empty bacterial envelopes of Gram-negative bacteria produced by controlled expressions of cloned gene E, forming a lysis tunnel structure within the envelope of the living bacteria. Globally, BGs have been used as vaccine delivery systems and vaccine adjuvants. There is an increasing interest in the development of novel delivery systems that are based on BGs for biomedical applications. Due to intact reservation of bacterial cell membranes, BGs have an inherent immunogenicity, which enables targeted drug delivery and controlled release. As carrier vehicles, BGs protect drugs from interference by external factors. In recent years, there has been an increasing interest in BG-based delivery systems against tumors, inflammation, and infection, among others. Herein, we reviewed the preparation methods for BGs, interactions between BGs and the host, and further highlighted research progress in BG development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available